Moclobemide and fluoxetine in atypical depression: a double-blind trial
- 30 November 1994
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 32 (3) , 169-177
- https://doi.org/10.1016/0165-0327(94)90015-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The validity of major depression with atypical features based on a community studyJournal of Affective Disorders, 1992
- Moclobemide Versus Clomipramine in Endogenous DepressionThe British Journal of Psychiatry, 1992
- Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depressionActa Psychiatrica Scandinavica, 1991
- Efficacy and Tolerability of Moclobemide Compared with Imipramine in Depressive Disorder (DSM-III): An Austrian Double-blind, Multicentre Study∗The British Journal of Psychiatry, 1989
- Predictors of Drug Response in DepressionArchives of General Psychiatry, 1989
- Fluoxetine Efficacy vs Comparative Drugs: An OverviewThe British Journal of Psychiatry, 1988
- Fluoxetine: Efficacy Against Placebo and by Dose-An OverviewThe British Journal of Psychiatry, 1988
- Antidepressant Specificity in Atypical DepressionArchives of General Psychiatry, 1988
- Phenelzine v Imipramine in Atypical DepressionArchives of General Psychiatry, 1984
- Endogenomorphic DepressionArchives of General Psychiatry, 1974